Vitamin or mineral? small study tests two supplements for autism

NCT ID NCT07383363

Completed Symptom relief Sponsor: Muhammad Aamir Latif Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested whether Vita 6 (a vitamin supplement) or zinc, each given alongside behavioral therapy, could reduce autism severity in children aged 3-12. Sixty-four newly diagnosed children who were not on any other treatment took part. The goal was to see if either supplement lowered their score on a standard autism rating scale after three months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Vita 6 (a vitamin supplement) and zinc sulfate
What this could lead to: If one treatment works better, it could offer a simple, safe option to help reduce autism severity in children when combined with behavioral therapy.
What could go wrong: This is a small, completed trial with only 64 children, so results may not apply to everyone. It compares two existing supplements, not a new breakthrough, and symptom improvement may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism spectrum disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTISM SPECTRUM DISORDER

Contacts and locations

Locations

Children Hospital and Institute of Child Health

Multan, Punjab Province, 66000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.